Insider Transactions in Q4 2021 at Strongbridge Biopharma PLC (SBBP)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 05
2021
|
Cdk Associates, L.L.C. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
8,060,682
-100.0%
|
-
|
|
Oct 05
2021
|
Stephen J Long Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
117,793
-100.0%
|
-
|
|
Oct 05
2021
|
David N Gill Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,058
-100.0%
|
-
|
|
Oct 05
2021
|
Garheng Kong Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
63,993
-100.0%
|
-
|
|
Oct 05
2021
|
Jeffrey W Sherman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
64,258
-100.0%
|
-
|
|
Oct 05
2021
|
Marten Steen Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
64,151
-100.0%
|
-
|
|
Oct 05
2021
|
Hilde H Steineger Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
64,258
-100.0%
|
-
|
|
Oct 05
2021
|
John Johnson Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
610,092
-100.0%
|
-
|
|
Oct 05
2021
|
Fredric J. Cohen Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
160,408
-50.0%
|
-
|
|
Oct 05
2021
|
Richard S Kollender President and CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
234,229
-100.0%
|
-
|
|
Oct 05
2021
|
Scott L. Wilhoit Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
109,510
-100.0%
|
-
|
|
Oct 01
2021
|
David N Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
17,763
-18.54%
|
$35,526
$2.06 P/Share
|
|
Oct 01
2021
|
Garheng Kong Director |
SELL
Payment of exercise price or tax liability
|
Direct |
17,763
-21.73%
|
$35,526
$2.06 P/Share
|
|
Oct 01
2021
|
Jeffrey W Sherman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
17,763
-21.66%
|
$35,526
$2.06 P/Share
|
|
Oct 01
2021
|
Hilde H Steineger Director |
SELL
Payment of exercise price or tax liability
|
Direct |
17,763
-21.66%
|
$35,526
$2.06 P/Share
|
|
Oct 01
2021
|
John Johnson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334,868
-35.44%
|
$669,736
$2.06 P/Share
|
|
Oct 01
2021
|
Marten Steen Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
17,763
-21.68%
|
$35,526
$2.06 P/Share
|
|
Oct 01
2021
|
Fredric J. Cohen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
51,548
-24.32%
|
$103,096
$2.06 P/Share
|
|
Oct 01
2021
|
Richard S Kollender President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
64,791
-21.67%
|
$129,582
$2.06 P/Share
|
|
Oct 01
2021
|
Stephen J Long Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,307
-29.51%
|
$98,614
$2.06 P/Share
|
|
Oct 01
2021
|
Scott L. Wilhoit Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,515
-20.08%
|
$55,030
$2.06 P/Share
|